Michael D. Anestis, PhD, executive director of the New Jersey Gun Violence Research Center and associate professor at the Rutgers School of Public Health, discusses his research on firearm ownership and suicide, in addition to steps needed to help decrease rates of gun-inflicted suicide and gun violence in general.
Gun violence is one of the most prominent public health issues facing America today, and accounted for over 43,500 deaths in 2020 alone—the highest number in decades. But a major driver of gun-related deaths in this country that often goes unmentioned is suicide.
Research shows that having access to a firearm significantly increases the risk of suicide via firearm, and during the pandemic, amid an unprecedented surge in firearm purchases, these purchasers appeared far more likely to have experienced suicidal ideation.
To learn more about the intersection between COVID-19, firearm ownership, and suicide, and to mark National Gun Violence Awareness Month, we spoke with Michael D. Anestis, PhD, an associate professor at the Rutgers School of Public Health.
On this episode of Managed Care Cast, Anestis discusses his most recent research on the paramount importance of safe firearm storage, this epidemic’s disproportionate impact on people of color, and future steps needed to help decrease rates of gun-inflicted suicide. Anestis also serves as the executive director of the New Jersey Gun Violence Research Center.
This episode of Managed Care Cast will discuss subjects related to suicide, suicide ideology, and gun violence. If you or a loved one is in crisis, please contact the National Suicide Prevention Lifeline at 800-273-8255.
Listen above or through one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More